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Dame, IndianaABSTRACT Ebola virus, from the Filoviridae family has a high fatality rate in humans and nonhuman primates and to date, to
the best of our knowledge, has no FDA approved vaccines or therapeutics. Viral protein 40 (VP40) is the major Ebola virus matrix
protein that regulates assembly and egress of infectious Ebola virus particles. It is well established that VP40 assembles on the
inner leaflet of the plasma membrane; however, the mechanistic details of VP40 membrane binding that are important for viral
release remain to be elucidated. In this study, we used fluorescence quenching of a tryptophan on the membrane-binding inter-
face with brominated lipids along with mutagenesis of VP40 to understand the depth of membrane penetration into lipid bilayers.
Experimental results indicate that VP40 penetrates 8.1 A˚ into the hydrocarbon core of the plasma membrane bilayer. VP40 also
induces substantial changes to membrane curvature as it tubulates liposomes and induces vesiculation into giant unilamellar
vesicles, effects that are abrogated by hydrophobic mutations. This is a critical step in viral egress as cellular assays demon-
strate that hydrophobic residues that penetrate deeply into the plasma membrane are essential for plasma membrane localiza-
tion and virus-like particle formation and release from cells.INTRODUCTIONEbola virus is from the Filoviridae family, which are some
of the most virulent pathogens that infect humans. These
infections, which are a health threat in Africa cause severe
hemorrhagic fevers with fatality rates up to 90% (1–4).
The Ebola virus is filamentous in shape and the genome con-
sists of single-stranded negative sense RNA encoding seven
proteins. The nucleocapsid, made of nucleoprotein, VP24,
VP30, VP35, and L protein, is crucial for viral transcription
and replication (5–7). The glycoprotein is exposed on the
surface of the viral envelope and is responsible for entry
of the virions through an interaction with Niemann-Pick
C1 in the host cell (8). The matrix proteins VP40 and
VP24, which associate with the viral lipid coat, are impor-
tant for the budding, virus structure, and stability (9–12).
VP40 is the most abundantly expressed protein of the virus
and has been shown to alone harbor the ability to form virus-
like particles (VLPs) when expressed in human cells
(13,14).
Previous studies on VP40 have shown that oligomeriza-
tion is a crucial step for budding (15–18), however, these
studies did not clarify the biophysical aspects of VP40
interactions with the plasma membrane (PM) or lipid
vesicles. Although the interaction of VP40 with the PM
remains poorly understood, several other viral matrix pro-
teins such as those from human immunodeficiency virus
type 1 (HIV-1) and vesicular stomatitis virus (VSV) have
been studied more extensively. For instance, the HIV-1
matrix domain (MA), which is myristoylated (19,20) hasSubmitted January 10, 2013, and accepted for publication March 12, 2013.
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(21–23) but also associate with the relatively abundant
PM anionic lipid phosphatidylserine (24,25). In addition,
the HIV-1 MA also associates with membranes in a
manner that is dependent upon cholesterol and the acyl
chain environment (26). A recent NMR study also demon-
strated the MA’s ability to associate with phosphatidylcho-
line, phosphatidylethanolamine, or phosphatidylserine
distinctly from PI(4,5)P2, which included an interaction
with the sn-2 acyl chain (27). For the VSV matrix protein
(28) at least two binding sites have been identified
with electrostatic interactions between the highly charged
N-terminal region and a loop region that mediates hydro-
phobic interactions with the membrane (28,29). Thus, for
both matrix proteins electrostatic interactions with the
negatively charged plasma membrane as well as hydropho-
bic interactions with the PM hydrocarbon region seem to
play an important role in PM binding. Taken together,
these MAs provide a means to compare differential modes
of viral matrix protein association with the PM and viral
budding.
VP40 consists of an N-terminal domain that has been
shown to mediate oligomerization and a C-terminal domain
has been shown to mediate lipid binding. Recently, the
C-terminal domain has been shown to penetrate the PM
through a hydrophobic patch (Fig. 1 A) that also is required
for VP40 oligomerization and viral egress (30). Thus, it is
essential to understand the nature of VP40 membrane inter-
actions, which may be a prerequisite to VLP formation and
release. In this study, we focused on how VP40 penetrates
lipid vesicles that recapitulate the PM of human cells using
fluorescence quenching techniques. This unique approachhttp://dx.doi.org/10.1016/j.bpj.2013.03.021
FIGURE 1 VP40 structure and lipid binding analysis. (A) The VP40 x-ray structure (PDB: 1ES6) with the N-terminal domain (dark gray) and C-terminal
domain (light gray) is shown. The N-terminal domain has been shown to be involved in oligomerization and the C-terminal domain has been deemed impor-
tant for membrane binding. Previous studies have demonstrated that a loop in the C-terminal domain consisting of Ile293, Leu295, and Val298 (shown in
magenta) penetrates the PM. Leu303, which has been shown to interact with Sec24C and is adjacent to this loop did not affect membrane penetration. To
investigate the depth of membrane penetration a Trp residue was introduced at position 299 (cyan). (B) A large unilamellar vesicle sedimentation was
used to test the ability of WT VP40, A299W, and the lactadherin C2 domain to bind POPC, POPC/POPS (80:20) or POPC/POPS/cholesterol (80:20:20).
The lactadherin C2 domain, which is a PS sensor, was used as a control. Experiments were repeated in triplicate. (C) A plot of equilibrium response
(RUeq) versus VP40 concentration is shown as determined with SPR. Briefly, a POPC/POPE/POPS (60:20:20) active surface and a POPC/POPE control sur-
face were used to determine the saturating response for different concentrations of VP40. The curve was then fit using nonlinear least squares analysis of the
binding isotherm using an equation, Req¼ Rmax/(1þKd/C). Experiments were repeated in triplicate to calculate the mean of the Kd and the standard deviation
as shown. (D) A plot of RUeq versus A299W concentration is shown as determined with SPR.
Ebola VP40 Deeply Penetrates the Membrane 1941allowed us to elucidate the membrane penetration depth of
VP40 together with site-directed mutagenesis we show is
an important determinant of VP40 PM localization, VP40-
induced membrane curvature changes, and VLP formation.MATERIALS AND METHODS
Lipid binding assays
The liposome sedimentation assays were performed as described
previously (31).Surface plasmon resonance (SPR)
SPR was used to compare the affinity of A299W to wild-type (WT)
VP40 for 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine/1-palmitoyl-
2-oleoyl-phosphatidylethanolamine/1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphatidylserine (POPC/POPE/POPS) (60:20:20) vesicles. All SPRmeasurements were performed at 25C as previously described (32,33).
A minimum of three data sets were collected for each lipid condition. Req
values (saturation response unit (RU) values) were then plotted versus
protein concentrations (C), and the Kd value was determined by a nonlinear
least squares analysis of the binding isotherm using an equation, Req ¼
Rmax/(1 þ Kd/C) (see Fig. 1 C and D). Each data set was repeated three
times to calculate a standard deviation value.Fluorescence measurements
Fluorescence measurements were made on an Aminco-Bowman series 2
Luminescence Spectrometer as previously described (34) with the
following modifications. All the measurements were made using excitation
at 284 nm and were performed at 25C. The tryptophan fluorescence emis-
sion spectra were scanned from 290 to 400 nm at 1 nm steps in a 200 ml
quartz fluorometer microcell (Starna Cells, Atascadero, CA). The data
were collected at a locked photomultiplier tube voltage of 750 volts, an
excitation bandwidth of 45 nm, an emission bandwith of 8 nm, and an
average of 3 emission scans/sample.Biophysical Journal 104(9) 1940–1949
1942 Soni et al.Depth of penetration calculation
The depth-dependent fluorescence quenching profiles (DFQP) are tools
used to analyze the changes in fluorescence depending on the depth of
the bromine label. The depth of the bromine positions has been calibrated
using x-ray diffraction experiments (35,36) and the depth of tryptophan was
determined using the distribution analysis (DA) method as described in
detail previously (37,38). The principle equation used for this method de-
scribes the quenching profile as a Gaussian:
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where F is the fluorescence intensity in the absence ðF0Þ and presence of
quencher ðFðhÞÞ, cðhÞ is the concentration of the quencher, S is the area,
s is the dispersion, h is the depth of the quencher, and hm is the mean depth.
Because, the concentration of different quenchers remained equal
throughout the experiments, cðhÞ ¼ 1. The left side of the expression is
termed the DFQP. The data were fit to a nonlinear curve fit Gaussian func-
tion using the Origin 8.6 program (OriginLab). The program yields the
value of hm, s, and Swith a confidence level of 95%. Samples were assessed
for statistical significance compared to the control using analysis of
variance in the Origin 8.6 software with a p value of 0.05 or less considered
statistically significant.Confocal imaging
Cells were imaged using a Zeiss LSM 710 confocal microscope using a
Plan Apochromat 63X 1.4 NA oil objective. The 488 nm line of the
Ar ion laser was used for excitation of enhanced green fluorescent protein
(EGFP). The laser power was maintained at 1% throughout the experiment
with the emission collected through a 493–556 nm filter. Number and
brightness analysis was performed as previously described (30,39) using
an Olympus FV1000 two-photon confocal microscope.VLP assays
To quantify VLP formation, EGFP-VP40, EGFP-VP40-I293A/A299W,
EGFP-VP40-L295A/A299W, EGFP-VP40-A299W (see Fig. 4 or Fig. S5
in the Supporting Material), or EGFP VLPs were isolated from cellular
media as previously described (13) 48 h posttransfection and assessed for
VP40 as we have previously described (30,39).Giant unilamellar vesicle (GUV) assays
An aliquot of lipids containing POPC, POPE, and POPS suspended in
chloroform was prepared in a 60:20:20 molar ratio for GUV formation as
previously described (40). Control experiments were performed with slight
changes in osmolarity in the absence of protein to demonstrate the speci-
ficity of 1 mM VP40-induced membrane curvature changes. Quantification
of GUVs was performed by imaging and counting at least 100 GUVs in
each experiment to determine if membrane vesiculation occurred. Experi-
ments were repeated in triplicate to calculate a standard deviation and
imaged as described previously.RESULTS
WT VP40 and A299W lipid binding analysis
It is well established that VP40 associates with the PM
through the C-terminal domain (1,39,41,42), which hasBiophysical Journal 104(9) 1940–1949been shown to include hydrophobic residues (Fig. 1 A)
that penetrate the PM (30). Although the role of this region
in VP40 membrane penetration and cellular localization is
appreciated, little information is available on the VP40
depth of membrane penetration. Thus, a VP40 mutant,
A299W was constructed to introduce a tryptophan into the
membrane binding C-terminal region to investigate the
depth of membrane penetration of VP40. To first demon-
strate the viability of A299W we assessed its in vitro and
cellular properties to ensure it behaved like WT VP40.
A299W had little effect on the fluorescence spectra of
VP40 (Fig. S1). To check the functionality of the mutant,
CHO-K1 cells were transfected with DNA expressing
EGFP-VP40-WT or EGFP-VP40-A299W as described in
experimental procedures. Images taken 12 h after transfec-
tion reveal the A299W mutant localized at the PM to a
similar extent to WT (see Fig. 4 A) where this mutant also
retained the ability to robustly form VLPs (see Fig. 4, B
and C). Number and brightness analysis in live cells also
showed that EGFP-VP40-WT and EGFP-VP40-A299W
oligomerize to a similar extent (Fig. S2). Taken together,
this verifies that the mutation does not affect VP40 localiza-
tion and function. In vitro, A299W retained WT lipid bind-
ing properties as evidenced by lipid vesicle sedimentation
assays (Fig. 1 B) and SPR where the Kd values of A299W
(180 5 40 nM) and WT (340 5 20 nM) for POPC/
POPE/POPS vesicles were comparable for experiments
repeated in triplicate (Fig. 1, C and D). Taking into consid-
eration the standard deviation for these experiments, the
moderate difference in Kd of ~220 to 320 nM (or 1.5-fold
difference in Kd) is not expected to play a significant role
in altering peripheral protein membrane binding or cellular
localization.Fluorescence quenching for WT and A299W
Quenching of the tryptophan fluorescence of VP40 protein
by brominated lipids was performed using a fluorescence
spectrophotometer. First, the stability of VP40 without lipid
vesicles was monitored at 25C for 60 min to ensure protein
stability throughout the necessary lifetime of experiments
(Fig. S1). Fluorescence spectra of VP40 WT and A299W in
phosphate buffered saline buffer are compared in Fig. S1.
Both proteins had a lmax at 340 nm. The fluorescence inten-
sity for A299Wwas higher thanWT, which can be attributed
to the additional tryptophan in the C-terminal domain of the
mutant. To test the ability of the protein to bind the vesicles,
protein was transferred via micropipette into the buffer con-
taining POPC/POPS vesicles and allowed to incubate for
30 min. PC/PS lipid vesicle aggregation was monitored by
measuring the scattering intensity before and after mixing
the protein (Fig. S3). The mutant, A299W, was slightly
quenched when mixed with PC/PS vesicles in the absence
of any brominated lipids (Fig. 2 A). Fluorescence quenching
can be attributed to the shielding of the additional tryptophan
FIGURE 2 Fluorescence quenching profile of VP40 and A299Wwith and without brominated lipids. (A) Fluorescence emission spectra (300 to 375 nm) of
WT VP40 (dashed line) and A299W (solid line) protein in the presence of POPC/POPS (80:20) vesicles. (B) Fluorescence emission spectra (300 to 375 nm)
spectra of WT VP40 (dashed line) and A299W (solid line) in the presence of PC/PS (80:20) vesicles containing 20 mol % Br(6,7)PC lipid vesicles in the
presence of POPC. (C) Plot of relative fluorescence quenching of WT VP40 or A299W protein before and after incubation with PC/PS vesicles (with or
without 20% Br(6,7)PC). Bovine serum albumin and the PKCa-C2 were used as negative and positive controls, respectively, under the same conditions.
Ebola VP40 Deeply Penetrates the Membrane 1943at position 299 upon insertion into the lipid membrane or
could result from shielding due to oligomerization.
Because the N-terminal tryptophans of WT protein are
not involved in membrane binding, no quenching of fluores-
cence was observed when WT protein was mixed with PC/
PS vesicles. Quenching efficiency was calculated by taking
the area under the curve of the fluorescence spectra and
plotted in Fig. 2 C. The bar graph shows 15% quenching
in fluorescence of A299W protein when bound to PC/PS
vesicles, whereas WT remained unchanged.
The protein spectra were then recorded in the presence of
brominated lipid where 20 mol % Br(6,7)PC was used to
replace 20 mol % POPC. Because of the additional trypto-
phan at position 299 in the membrane-binding interface
the quenching of A299W was noticeably reduced compared
to WT (Fig. 2 B). The area under the curve, plotted in Fig. 2
C for WT and A299W mutant, compares the quenching in
the absence and presence of brominated lipids. The quench-
ing of A299W was reduced by 36% in the presence of
brominated lipids. As expected, the fluorescence for WT
remained unaffected with Br(6,7)PC containing vesicles.
Bovine serum albumin, a nonlipid membrane insertingprotein, was used as a negative control, and PKC-C2a was
used as a positive control (43), as it has two Trp residues
on the membrane-binding interface and slightly penetrates
PS-containing membranes. Thus, it is concluded that the
C-terminal domain of VP40 not only binds but also inserts
into the lipid membrane.Depth of penetration of VP40 with different
brominated lipids
To determine the depth of penetration of VP40 into the lipid
vesicles, we used vesicles composed of selectively labeled
brominated lipid chains. The WT protein fluorescence
with lipid vesicles containing 20 mol % Br(6,7)PC,
Br(9,10)PC, or Br(11,12)PC was not sensitive to the
quenchers as the N-terminal tryptophans are located outside
the range of the brominated lipids’ quenching ability (Fig. 3
A or Fig. S4 A). Using data from Br(6,7)PC, Br(9,10)PC,
and Br(11,12)PC lipids revealed the maximum fluorescence
quenching for A299W protein in the presence of lipid
vesicles containing Br(9,10)PC (Fig. 3 A or Fig. S4 B).
The quenching from Br(9,10)PC is ~53%, which isBiophysical Journal 104(9) 1940–1949
FIGURE 3 Histograms of the fluorescence quenching change forWTVP40, A299W, AW/L295A, and AW/I293A using brominated lipids on different acyl
chain positions. (A) Plot of relative fluorescence quenching for WT VP40 and A299W in the absence and presence of specifically labeled 20% brominated
PC/PS vesicles were collected at room temperature. Lipid and protein were incubated for 20 min before collecting the spectra. (B) Depth of penetration into
the membrane calculated for VP40-A299W. Depth of penetration was calculated as described in the Methods. Using the Gaussian function in the Origin 8.6
pro program with a confidence limit of 95% the mean depth (hm), dispersion of the probe (s), and the area under the depth-dependent fluorescence quenching
(S) were determined. (C) Spectra were collected for PM and NM mimetics mixed with A299Wat room temperature. Fluorescence quenched by each vesicle
composition were quantified and plotted in triplicate to determine the standard deviation. (D) Spectra were collected for protein alone or protein in the
presence of PC, PC/PS, PM, or NM vesicles with the AW/L295A or AW/I293A mutants. Experiments were repeated in triplicate to calculate a standard
deviation. ns ¼ not statistically significant, ** p ¼ 0.006.
1944 Soni et al.considerably higher than that achieved by Br(6,7)PC con-
taining vesicles. However, the quenching was only 9%
higher with Br(9,10)PC in the vesicles as compared to
when Br(11,12)PC was incorporated into the vesicles. A
comparison of the WTand A299Wmutant reveals sustained
fluorescence for the WT protein and substantial quenching
of the mutant (Fig. 3 A). Overall, these data suggest that
the integrated tryptophan is closest to the 9th and 10th car-
bons of the acyl chain as the quenching is dependent on the
distance between the tryptophan and the position of bromine
on the lipid acyl chain (44). The data also suggest the tryp-
tophan is closer to the 11th and 12th carbon than to the 6th
and 7th carbon as the quenching for Br(11,12)PC is 8%
more than that of Br(6,7)PC.
The DFQP was determined using the DA method as
described in detail previously (37,38) as well as in the exper-
imental procedures. The data were fit to a nonlinear curve fit
Gaussian function of the commercial software Origin 8.6,
which yielded a mean depth of hm ¼ 8:1 A˚ (Fig. 3 B). TheBiophysical Journal 104(9) 1940–1949dispersion of the probe s ¼ 3.2 A˚ and the area under the
curve S ¼ 16.7 A˚ were also determined. Largely, the results
suggested the VP40 C-terminal domain penetrated 8.1 A˚
into the hydrocarbon core of the membrane or more than
halfway into one PC/PS monolayer. Unlike the parallax
method (45,46) the DA method is independent of the con-
centration of the quencher in the membrane (37). To confirm
this finding we tested the concentration dependency of
quencher in the lipid vesicles demonstrating there was not
a significant effect on the depth of penetration of the
A299W protein (Fig. S7).Plasma membrane and nuclear membrane
mimetics
VP40 is known to accumulate at the PM (41) before budding
and egress, and Adu-Gyamfi et al. (30) have recently shown
that VP40 can penetrate membranes that recapitulate the
PM but not the nuclear membrane. In addition, VP40 binds
Ebola VP40 Deeply Penetrates the Membrane 1945with nanomolar affinity to vesicles that recapitulate the in-
ner leaflet of the plasma membrane (30). Previously, mem-
brane mimetics have been used to characterize the binding
of peripheral proteins to membranes (30,47). Briefly,
analysis of different cellular membranes from rat liver
(48) combined with several experimentally supported as-
sumptions on bilayer asymmetry (33,49) allows for mem-
brane mimetics to more closely recapitulate the lipid
compositions of biological membranes. To mimic the PM
composition we prepared vesicles composed of POPC/
POPE/POPS/cholesterol (20:36:22:22, molar ratio) and ves-
icles mimicking the nuclear membrane (NM), (POPC/
POPE/POPS/cholesterol 67:22:4:7, molar ratio), were used
as a control. The fluorescence spectra revealed a very strong
quenching for PM-like vesicles when mixed with the
A299W mutant protein as compared to NM (Fig. 3 C).
The fluorescence quenching for A299W in the presence of
PM-like vesicles was found to be ~60% compared to ~2%
for vesicles representing the NM.C-terminal hydrophobic mutant studies
Adu-Gyamfi et al. (30) demonstrated that a loop containing
Ile293, Leu295, and Val298 in the C-terminal domain pene-
trates the PM. To assess the role of these mutations in the
depth of VP40 penetration, we mutated Ile293 and Leu295
into the A299W construct so we could probe for the depth
of penetration. This created the double mutations A299W-
I293A (AW/I293A) and A299W-L295A (AW/L295A).
The fluorescence spectra of the mutants incubated with
PC vesicles did not have a statistically significant effect
on the quenching for either AW/I293A or AW/L295A
(Fig. 3 D). As expected from the membrane penetration
data, the fluorescence quenching of AW/I293A or AW/
L295A in the presence of PC/PS, PM, or NM vesicles was
not significantly changed. Thus, in line with previous studies
on VP40 that removed the C-terminus and displayed a loss
of VP40 membrane association (15,41), we show that VP40
deeply penetrates lipid membranes, especially those that
mimic the PM using a loop region consisting of Ile293,
Leu295, and Val298 (see Fig. 1 A and Fig. 6, B and C).Mutation of hydrophobic C-terminal domain
residues disrupts PM localization and abrogates
viral egress
To further analyze the effect of the hydrophobic mutants in
cells, we transfected CHO-K1 cells with plasmids encoding
WT EGFP-VP40, A299W, AW/I293A, and AW/L295A.
The cells were imaged 12 h posttransfection using confocal
microscopy. As shown in Fig. 4, WT and A299W were pre-
dominantly localized to the PM with strong visual evidence
of VLP extensions emanating from the PM. On the contrary,
images for AW/I293A and AW/L295A display diffuse cyto-
solic localization, a reduction in PM localization, and a lossof evident VLP egress consistent with their role in PM
penetration.
To further investigate the role of the membrane penetra-
tion in VLP egress we collected VLPs for each construct
48 h posttransfection as described in the Methods. The iso-
lated VLP and cell lysate were subjected to western blot
(Fig. 4 B), with blotting for GAPDH as a loading control.
Western blot results confirmed the previously obtained fluo-
rescence and imaging results that WT and A299W had a
similar release of VLPs from the cell, whereas the double
mutations, AW/I293A and AW/L295A, display little detect-
able release of VLPs (Fig. 4 B and C). Taken together, the
significant depth of membrane penetration by the C-termi-
nal domain of VP40 is important for PM localization and
critical to viral egress.VP40 induces membrane curvature changes
The matrix protein of Newcastle disease virus (NDV) has
been shown to induce membrane curvature changes into
GUVs in the form of vesiculation that forms as the matrix
protein buds into the GUV (i.e., negative curvature changes)
(50), which is likely a critical step in viral egress. To inves-
tigate if VP40 is able to induce changes to membrane curva-
ture by inserting deeply into the membrane, we employed
electron microscopy (EM) and GUV assays. As shown in
Fig. 5, EM indicates that VP40 is able to induce tubule for-
mations in ~20% of the PC/PE/PS liposomes imaged. This
effect is abrogated when these liposomes were incubated
with L213A, L295A, or V298A as tubulation was undetect-
able. It is difficult to decipher if a protein is budding into
liposomes or creating tubules extending from liposomes in
EM imaging. GUVs are better able to resolve the type of
membrane curvature generated as vesiculation or tubulation
can be visualized as either entering into or emanating from
the GUV. Indeed, when VP40 was incubated with GUVs it
induced vesiculation into the GUV (605 5% of GUVs) in a
similar fashion to that reported for the NDV matrix protein
(see Fig. 6 A). On the contrary, this effect is abrogated when
L295A (55 2% of GUVs) is observed under the same con-
ditions (see Fig. 6 A).DISCUSSION
VP40 assembles on the inner leaflet of the PM of host cells
where it oligomerizes (39) and regulates viral egress. Inhibi-
tion of the membrane-binding step leads to downregulation
of Ebola virus production (15,41). The molecular details of
VP40 membrane association are still poorly understood
so we mutated a tryptophan at position 299 of the VP40
C-terminal domain to investigate the mechanism of VP40
membrane penetration and VLP release. Here, we focused
on how deeply VP40 penetrates membrane bilayers and
how this correlates with VLP egress. The presence of a
Trp residue in the region that penetrates the membraneBiophysical Journal 104(9) 1940–1949
FIGURE 4 Cellular localization and VLP release of WT VP40 and C-terminal domain mutations tagged with EGFP. (A) CHO-K1 cells were imaged after
12 h to assess VP40 localization for WTand each mutant. Images are representative of>100 transfected cells visualized for each construct. (B) CHO-K1 cell
lysate and VLPs were collected after 48 h and were subjected to western blot with anti-EGFP. The ratio of cell lysate to VLPs was maintained for each sample
with GAPDH used as a loading control for total cell density. (C) The western blot band intensities were determined using NIH Image J. The band intensities
were calculated with respect to amount of GAPDH in the samples and then normalized to WT VP40. A histogram was plotted to compare the VLP egress
(ratio of VP40 in VLPs/VP40 in cell lysate) for each of the VP40 mutants. Experiments were repeated in triplicate to calculate a standard deviation as shown.
** p < 0.006; ns ¼ not significant.
1946 Soni et al.bilayer was used in combination with brominated lipids at
different acyl chain positions to calculate the depth of
VP40 membrane penetration.
Fluorescence data in the presence of brominated lipids at
different acyl chain positions demonstrated that the VP40
C-terminal domain penetrates 8.1 A˚ into the hydrocarbon
core using the DA method. This is significant as this depth
of membrane penetration would insert VP40 more than
halfway through one monolayer of the PC/PS or PM bilayer.
This deep penetration into the membrane seems to play a
critical role in VLP release as hydrophobic mutations
(I293A and L295A) that reduce the deep membrane penetra-
tion decrease PM localization and abrogate VLP release.
Notably, I293A and L295A reduce membrane penetration
of VP40 in an in vitro monolayer assay and single mutations
(without A299W) greatly reduce VP40 oligomerization
(30), which is a hallmark of Ebola infectivity (13,17,51).
Note that for AW/I293A and AW/L295A (Fig. 4 A) some
PM localization was still evident as were filaments extend-
ing from the PM, but VLP egress was nearly undetectable by
a western blot assay. Thus, it’s possible VP40 can still asso-
ciate with the PM when membrane penetration is signifi-Biophysical Journal 104(9) 1940–1949cantly reduced but the late stages of budding are affected
such as VLP release. Generally, hydrophobic interactions
are responsible for membrane residence time of peripheral
proteins as they slow the rate of membrane dissociation
(52). Under these conditions I293A and L295A may still
associate but have reduced residence time, oligomerization,
and VLP release. The methodologies reported here employ-
ing a Trp for depth of penetration analysis certainly has its
caveats. For instance, depth of penetration results are
limited to the hydrophobic patch in the C-terminal domain
of VP40 where Trp at 299 is located. Nonetheless, this study
should serve as a building block for generating a more com-
plete picture of VP40 oligomers bound to lipid membranes.
VP40 may be similar to the VSV matrix protein in its
lipid-binding properties because a highly charged N-termi-
nal region of VSV matrix has been shown to engage in
electrostatic interactions with membranes while also under-
going hydrophobic interactions with several exposed hydro-
phobic residues (28,29). However, VP40 membrane docking
seems to differ somewhat from that of the HIV-1 MAwhere
MA is primarily bound to the membrane through electro-
static interactions with phosphoinositides where only matrix
FIGURE 5 VP40 induces membrane deformation. (A) Transmission electron microscopy was used to assess the ability of VP40 and mutants to induce
changes to liposomemorphology. All measurements were donewith 1 mMprotein in 20 mMHEPES, pH 7.4, containing 160 mMKCl. (B) WT VP40 induced
tubulation (tubules circled in black) of POPC/POPE/POPS liposomes. However, mutations (C) L213A (D) L295A, or (E) V298A abrogated or significantly
reduced liposome tubulation. Scale bar ¼ 500 nm.
Ebola VP40 Deeply Penetrates the Membrane 1947domain Lys and Arg residues protrude peripherally into the
lipid headgroup region (53). Interestingly, a recent NMR
study also demonstrated the HIV-1 MA’s ability to associate
with phosphatidylcholine, phosphatidylethanolamine, or
phosphatidylserine distinctly from PI(4,5)P2, which
included an interaction with the sn-2 acyl chain of these
lipids (27). In this model, the sn-2 chain engaged by the
HIV-1 matrix would be slightly pulled out of the membrane
and together with myristate and PI(4,5)P2 provides three
distinct points of contact with the membrane. In addition,
the HIV-1 MA also associates with membranes in a manner
that is dependent upon cholesterol and the acyl chain envi-
ronment (26). These types of intricate molecular details are
not yet known for VP40 but with the current high-resolution
methods available to study lipid-protein interactions they
should be investigated to fully resolve how VP40 engages
the complex network of PM lipids.
The type of membrane penetration mechanism we pro-
pose for VP40 (Fig. 6 C) may be advantageous for filovi-
ruses as these particles need time to assemble at the inner
leaflet of the PM to recruit the nucleocapsid. VP40, unlike
HIV-1MA, is not myristoylated and would require sufficient
interactions with the membrane bilayer and/or receptor pro-
teins at the PM to oligomerize and build the filamentous
viral particle. Our data indicate a loss of even one key hydro-
phobic contact with the membrane bilayer may be sufficient
to greatly reduce egress of VP40. The deep membrane pene-
tration and the requirement of VP40 to oligomerize to egress
the cell (17) is striking as often peripheral proteins with
these properties can bend membranes. Indeed, EM and
GUV assays demonstrate that VP40 can induce tubule for-mation from liposomes and induce vesiculation into
GUVs. Analysis of hydrophobic mutations demonstrates
that when the ability of VP40 to deeply penetrate the mem-
brane is reduced, detectable membrane curvature changes
are lost. Previously, it has been shown that the matrix protein
from NDV has membrane bending properties (50) and could
form vesicles into GUVs. Of importance, both VP40 and
NDV seem to induce negative curvature changes or budding
away from the leaflet they are bound to, which is consistent
with pushing or bending the PM out of the cell. The ability
of VP40 to egress mammalian cells in the absence of other
viral proteins and in tandem with membrane penetration
data presented here may suggest an active role of VP40 in
regulating PM structure and perhaps even the scission
step. Taken together, these studies demonstrate the useful-
ness of integrating in vitro biophysical assays with cellular
imaging and VLP egress to better understand the role of
lipid-protein interactions in viral budding. Investigating
the ability of VP40 to bend membranes should help to better
understand Ebola virus egress and the role of VP40 in the
formation of the filamentous viral particle.SUPPORTING MATERIAL
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